Format

Send to

Choose Destination
Oxid Med Cell Longev. 2017;2017:6469138. doi: 10.1155/2017/6469138. Epub 2017 Jan 5.

Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review.

Author information

1
Department of Surgery and Physiology, Ophthalmology Unit, Faculty of Medicine of University of Porto, Porto, Portugal; Service of Ophthalmology, Hospital S. João, Al. Professor Hernâni Monteiro, 4200-319 Porto, Portugal.
2
Department of Biomedicine, Anatomy Unit, Faculty of Medicine of University of Porto, Al. Professor Hernâni Monteiro, 4200-319 Porto, Portugal; Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine, University of Porto, Rua Dr. Plácido da Costa, 4200-450 Porto, Portugal.

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. In this narrative review, we will summarize the nutritional interventions evaluated in numerous observational studies and a few randomized clinical trials. The AREDS and AREDS2 studies demonstrated that supplements including vitamins C and E, beta-carotene, and zinc may reduce the progression to advanced AMD, in some patients, by 25% in five years. This is one of the few nutritional supplements known to have beneficial effects in any eye disease. Lutein/zeaxanthin supplementation may have beneficial effects in some individuals whereas omega-3 fatty acids supplementation needs to be further investigated and supported by more evidence. Genetic factors may explain the different patterns of response and explain differences found among individuals. More importantly, a combination of lifestyle behaviors such as the avoidance of smoking, physical activity, and the adoption of a healthy dietary pattern like the Mediterranean diet was associated with a lower prevalence of AMD. The adoption of these lifestyles may reduce the prevalence of the early stages of AMD and decrease the number of individuals who develop advanced AMD and consequently the onerous and climbing costs associated with the treatment of this disease.

PMID:
28154734
PMCID:
PMC5244028
DOI:
10.1155/2017/6469138
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center